vivus calls it quits on testosterone drug, page-7

  1. 205 Posts.
    Hardoak, agree with you.
    I wouldn't be surprised if Eli Lilly wasn't real keen after their initial deal with Acrux a couple of weeks prior plus Eli Lilly have deep deep pockets and a great sales team to promote all of the Acrux products. By the way Hardoak you are well named, are you in the Acrux testosterone trial by any chance.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.7¢
Change
0.001(6.25%)
Mkt cap ! $6.931M
Open High Low Value Volume
1.6¢ 1.7¢ 1.6¢ $5.481K 329.8K

Buyers (Bids)

No. Vol. Price($)
2 41559 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 200000 1
View Market Depth
Last trade - 13.54pm 27/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.